The second batch of state-owned enterprises reform pilot is expected to start 1 billion 100 million -tataufo

The second batch of pilot reform of state-owned enterprises is expected to start the 1 billion 100 million fund Level2:A shares 19 shares of Sina Financial counter attack speed Kanpan sina finance App: Live on-line blogger to tutor – reporter Ren Xiaoyu with the "1+N" policy launched, SOE reform entered the implementation stage. Recently, there is news that the relevant departments recently for state-owned enterprises "reform of the ten pilot held a press conference, or will start the second batch of pilot reform of state-owned enterprises. Insiders pointed out that the reform of state-owned enterprises this year, the depth will be further increased, "ten pilot" will be pushed from point to surface, in mergers and acquisitions, mixed reform, ESOP, the overall listing and other areas will accelerate exploration. Affected by this, yesterday the concept of SOE reform sector performed well, Jihua Group, Shanghai Putian, water fisheries to achieve the limit, Andy and su (8.21%), Hunan Science & Technology (6.64%), Dongan (6.52%), long joint development (6.50%), Yinhai (5.34%), long (5.24%), David Yi Hua. Gene (5.22%), IFAD (5.06%) and Yueyang (5.04%) Xingchang stocks rose more than 5%. Capital flows, according to the "Securities Daily" display Market Research Center statistics, a total of 80 stocks showed a net inflow of large single trend, the sector yesterday, a large net inflow of funds of more than 10 million yuan has 37, Jihua Group topped the single net inflow of funds reached 536 million 128 thousand and 900 yuan, followed by water fisheries Shanghai Putian, large single net capital inflows are more than 50 million yuan, reached 88 million 491 thousand and 100 yuan, 58 million 144 thousand and 600 yuan, while the nuclear science and Technology (41 million 998 thousand and 900 yuan), Yi Hualu (41 million 641 thousand and 400 yuan), tat gene (39 million 371 thousand and 300 yuan), Sanyou chemical (39 million 324 thousand and 400 yuan), Lida optical (36 million 866 thousand yuan), Panzhihua vanadium (35 million 11 thousand and 500 yuan), Dong’e gelatin (26 million 562 thousand yuan), the development of space (25 million 906 thousand and 200 yuan), Shenzhen sed A (25 million 812 thousand and 600 yuan), long joint development (25 million 661 thousand and 400 yuan ), Yangtze Power (24 million 892 thousand and 800 yuan), Xinxing Pipes (24 million 522 thousand yuan), copote science and Technology (23 million 138 thousand and 800 yuan), China nuclear power (22 million 968 thousand and 100 yuan), the Great Northern Wilderness (21 million 916 thousand and 200 yuan) and Yueyang Xingchang (21 million 62 thousand yuan) and other 16 stocks of large single capital inflows more than 20 million yuan, the 19 related stocks yesterday, the cumulative suction gold 1 billion 159 million yuan. This year, the central enterprises restructuring are frequent. In February 18th, China National Pharmaceutical Group Corp announced the suspension of the Tiantan biological event due to major events, but the company did not notice the specific reason for the suspension. On the same day, the National Pharmaceutical Group, which belongs to the Chinese Pharmaceutical Group, also announced the suspension. Prior to 1 25, Chinese building materials group and China Materials Group’s total 12 A shares and 2 H-share listed companies have announced that the company received a controlling shareholder of the respective general

第二批国企改革试点有望启动 11亿资金逆袭19股 新浪财经Level2:A股极速看盘 新浪财经App:直播上线 博主一对一指导   ■本报记者 任小雨   随着“1+N”政策相继推出,国企改革步入全面实施阶段。日前,有消息称,相关部门近日将针对国企“十项改革试点”召开发布会,或将启动第二批国企改革试点。业内人士指出,今年国企改革力度、深度将进一步加大,“十项试点”将从点到面全面推开,在并购重组、混改、员工持股、整体上市等多个领域将加快探索。   受此影响,昨日国企改革概念板块表现出色,际华集团、上海普天、中水渔业实现涨停,而安迪苏(8.21%)、湘邮科技(6.64%)、东安动力(6.52%)、久联发展(6.50%)、久远银海(5.34%)、易华录(5.24%)、达安基因(5.22%)、农发种业(5.06%)和岳阳兴长(5.04%)等个股涨幅均超过5%。   资金流向方面,据《证券日报》市场研究中心统计显示,昨日板块内共有80只概念股呈现大单资金净流入态势,其中,大单资金净流入超过1000万元的个股有37只,际华集团大单资金净流入居首达到53612.89万元,紧随其后的中水渔业、上海普天大单资金净流入额也均超过5000万元,分别达到8849.11万元、5814.46万元,而中核科技(4199.89万元)、易华录(4164.14万元)、达安基因(3937.13万元)、三友化工(3932.44万元)、利达光电(3686.60万元)、攀钢钒钛(3501.15万元)、东阿阿胶(2656.20万元)、航天发展(2590.62万元)、深桑达A(2581.26万元)、久联发展(2566.14万元)、长江电力(2489.28万元)、新兴铸管(2452.20万元)、湘邮科技(2313.88万元)、中国核电(2296.81万元)、北大荒(2191.62万元)和岳阳兴长(2106.20万元)等16只概念股大单资金净流入均在2000万元以上,上述19只相关概念股昨日累计吸金11.59亿元。   今年以来,央企重组频现。2月18日,中国医药集团总公司旗下的天坛生物宣布因重大事项停牌,但公司并未公告停牌具体原因。而就在同日,同属中国医药集团的国药股份也宣布停牌。在此之前的1月25日,中国建筑材料集团与中国中材集团旗下的共12家A股上市公司及2家H股上市公司均发布公告称,公司接到各自控股股东的通知,控股股东正在筹划战略重组事宜,但重组方案尚未确定。   针对板块的投资机会方面,分析人士表示,作为首批试点的中粮系与国投系,一直是市场认可的国企改革主题投资的龙头,预计第二批央企试点尤其是国有资本投资公司和国有资本运营公司试点同样有望成为市场关注的热点。可以关注中国诚通系、招商局系的试点预期。相关个股有:中储股份、冠豪高新、岳阳林纸等。同时,预计旨在转向“管资本为主”的国有资本投资与运营公司试点在各个地方层面也会展开,这些平台系公司也将成为国企改革主题投资中的重中之重。 进入【新浪财经股吧】讨论相关的主题文章: